This company has been marked as potentially delisted and may not be actively trading. Intensity Therapeutics, Inc. Common stock (INTS) Earnings Date, Estimates & Call Transcripts Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesOwnershipShort InterestTrendsBuy This Stock Intensity Therapeutics, Inc. Common stock Earnings Summary Intensity Therapeutics, Inc. Common stock issued Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.22, which missed the consensus estimate of -$0.21 by $0.01. With a trailing EPS of -$1.07, Intensity Therapeutics, Inc. Common stock's earnings are expected to grow next year, from ($1.18) to ($1.00) per share. Latest Q1 Earnings DateMay. 13EstimatedConsensus EPS (May. 13) -$0.21 Actual EPS (May. 13) -$0.22 Missed By -$0.01 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)Powered by Get Intensity Therapeutics, Inc. Common stock Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Intensity Therapeutics, Inc. Common stock and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataINTS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Intensity Therapeutics, Inc. Common stock Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.28-$0.28-$0.28Q2 20251-$0.31-$0.31-$0.31Q3 20251-$0.33-$0.33-$0.33Q4 20251-$0.35-$0.35-$0.35 Intensity Therapeutics, Inc. Common stock Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025-$0.21-$0.22 -$0.01-$0.22--3/13/2025Q4 2024-$0.23-$0.22+$0.01-$0.22--8/9/2024--$0.32-$0.36 -$0.04-$0.36--5/9/2024Q1 2024--$0.34 -$0.34-$0.34--3/14/2024Q4 2023--$0.12 -$0.12-$0.12--11/13/2023Q3 2023--$0.17 -$0.17-$0.17--8/14/2023Q2 2023--$1.43 -$1.43-$1.43-- Intensity Therapeutics, Inc. Common stock Earnings - Frequently Asked Questions When did Intensity Therapeutics, Inc. Common stock announce their last quarterly earnings? Intensity Therapeutics, Inc. Common stock (NASDAQ:INTS) last announced its quarterly earning data on Tuesday, May 13, 2025. Learn more on INTS's earnings history. Did Intensity Therapeutics, Inc. Common stock beat their earnings estimates last quarter? In the previous quarter, Intensity Therapeutics, Inc. Common stock (NASDAQ:INTS) missed the analysts' consensus estimate of ($0.21) by $0.01 with a reported earnings per share (EPS) of ($0.22). Learn more on analysts' earnings estimate vs. INTS's actual earnings. How much profit does Intensity Therapeutics, Inc. Common stock generate each year? Intensity Therapeutics, Inc. Common stock (NASDAQ:INTS) has a recorded net income of -$10.54 million. INTS has generated -$1.07 earnings per share over the last four quarters. What is Intensity Therapeutics, Inc. Common stock's EPS forecast for next year? Intensity Therapeutics, Inc. Common stock's earnings are expected to grow from ($1.18) per share to ($1.00) per share in the next year. More Earnings Resources from MarketBeat Related Companies Protara Therapeutics Earnings Results Protalix BioTherapeutics Earnings Results Cardiol Therapeutics Earnings Results Cabaletta Bio Earnings Results Sangamo Therapeutics Earnings Results Exozymes Earnings Results Caribou Biosciences Earnings Results Tenaya Therapeutics Earnings Results C4 Therapeutics Earnings Results Invivyd Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Broadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal This page (NASDAQ:INTS) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s worst nightmareThe President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intensity Therapeutics, Inc. Common stock Please log in to your account or sign up in order to add this asset to your watchlist. Share Intensity Therapeutics, Inc. Common stock With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INTS Stock Free INTS Stock Alerts